Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Signaling Pathway G Protein Signaling Small G Proteins Other

Human POT1 peptide (ab23432)

Human POT1 peptide (ab23432)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Suitable for: Blocking

You may also be interested in

Product image
p38 MAPK alpha ELISA Kit (ab221012)
Product image
Anti-Nucleoporin p62/NUP62 antibody [EPR9919] - BSA and Azide free (ab248931)
Product image
Anti-Synaptojanin antibody [AC1] (ab24591)
Product image
Human ATG4A knockout HeLa cell line (ab265738)

Description

  • Product name

    Human POT1 peptide
  • Animal free

    No
  • Nature

    Synthetic
    • Species

      Human

Preparation and Storage

  • DKFZP586D211
  • hPot 1
  • hPot1

Images

  • Western blot - Human POT1 peptide (ab23432)
    Western blot - Human POT1 peptide (ab23432)

    ab21382 detects a band at ~78kDa corresponding to Pot1. This activity of the antibody is quenched by the addition of the immunizing peptide (ab23432). A number of smaller, weaker bands are also detected. We believe these represent degradation products.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.